These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 118371)

  • 1. Reversion of nonsense mutants induced by 4-nitroquinoline-1-oxide in Schizosaccharomyces pombe.
    Janner F; Flury F; Leupold U
    Mutat Res; 1979 Nov; 63(1):11-9. PubMed ID: 118371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differentiation between amber and ochre mutants of yeast by reversion with 4-nitroquinoline-1-oxide.
    Prakash L; Sherman F
    Genetics; 1974 Jun; 77(2):245-54. PubMed ID: 4603163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct selection of mutants influencing gene conversion in the yeast Schizosaccharomyces pombe.
    Thuriaux P
    Mol Gen Genet; 1985; 199(3):365-71. PubMed ID: 3861928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of a UGA-suppressing serine tRNA from Schizosaccharomyces pombe with the help of a new in vitro assay system for eukaryotic suppressor tRNAs.
    Kohli J; Kwong T; Altruda F; Söll D; Wahl G
    J Biol Chem; 1979 Mar; 254(5):1546-51. PubMed ID: 762155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 4-Nitroquinoline-1-oxide: factors determining its mutagenicity in bacteria.
    McCoy EC; Petrullo LA; Rosenkranz HS; Mermelstein R
    Mutat Res; 1981 Jun; 89(2):151-9. PubMed ID: 6793865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Schizosaccharomyces pombe sup3-i suppressor recognizes ochre, but not amber codons in vitro and in vivo.
    Hottinger H; Stadelmann B; Pearson D; Frendewey D; Kohli J; Söll D
    EMBO J; 1984 Feb; 3(2):423-8. PubMed ID: 6370683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Molecular nature of the direct mutations induced by 4-nitro-quinoline-N-oxide and 3-methyl-4-nitroquinoline-N-oxide in the ADE2 gene of Saccharomyces cerevisiae].
    Kasinova GV; Gracheva LM
    Genetika; 1985 Jun; 21(6):914-8. PubMed ID: 3928438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutagenicity of N2 guanylarylation is SOS functions dependent and reminiscent of the high mutagenic property of 4NQO.
    Galiègue-Zouitina S; Daubersies P; Loucheux-Lefebvre MH; Bailleul B
    Carcinogenesis; 1989 Oct; 10(10):1961-6. PubMed ID: 2507192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the mutagenic spectrum of 4-nitroquinoline 1-oxide (4-NQO) in Aspergillus nidulans by whole genome sequencing.
    Downes DJ; Chonofsky M; Tan K; Pfannenstiel BT; Reck-Peterson SL; Todd RB
    G3 (Bethesda); 2014 Oct; 4(12):2483-92. PubMed ID: 25352541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific inhibitors of the monooxygenase system of Saccharomyces cerevisiae modified the mutagenic effect of 4-nitroquinoline 1-oxide and the deethylation activity of the yeast.
    Del Carratore R; Cundari E; Vellosi R; Galli A; Bronzetti G
    Carcinogenesis; 1986 Jul; 7(7):1127-30. PubMed ID: 3087645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Counteracting effect of eosin and related dyestuffs on the production of respiration-deficient mutants in yeast by 4-nitroquinoline 1-oxide.
    Nagai S
    Mutat Res; 1976 Feb; 34(2):187-94. PubMed ID: 814454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toxicity of 4-nitroquinoline 1-oxide for Crithidia fasciculata.
    Leon W; Cruz FS; Vasconcellos ME
    J Protozool; 1975 May; 22(2):277-80. PubMed ID: 50443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between sensitivity of cells from patients with hereditary cutaneous malignant melanoma to killing and mutations by 4-nitroquinoline 1-oxide and adduct formation.
    Sato K; Howell JN; Greene MH; Maher VM; McCormick JJ
    Cancer Res; 1988 Sep; 48(18):5145-50. PubMed ID: 3136916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutagen specificity and position effects on mutation in T4rII nonsense sites.
    Ronen A; Rahat A
    Mutat Res; 1976 Jan; 34(1):21-34. PubMed ID: 1250247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular biology of 4-nitroquinoline 1-oxide in the prokaryotic system.
    Kondo S
    Carcinog Compr Surv; 1981; 6():47-64. PubMed ID: 6786745
    [No Abstract]   [Full Text] [Related]  

  • 16. [Inhibition of the process of 4-nitroquinoline-1-oxide-induced DNA break repair in chronically virus-infected human cells].
    Zasukhina GD; Bogomolova NN; Vostrova NG; Kolonina IV; Desiatskova RG
    Vopr Virusol; 1981; (1):94-7. PubMed ID: 6789556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Herpes virus inactivation by chemical carcinogens: differential inactivation of herpes simplex viruses by 4-nitroquinoline 1-oxide and related compounds.
    Speelman D; Li JL; Ramanujam VM; Legator MS; Albrecht T
    Environ Mutagen; 1981; 3(4):467-76. PubMed ID: 6266824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Organisation of the complex locus trp1 in the fission yeast Schizosaccharomyces pombe.
    Thuriaux P; Heyer WD; Strauss A
    Curr Genet; 1982 Oct; 6(1):13-8. PubMed ID: 24186364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The major cause of inactivation and mutation by 4-nitroquinoline 1-oixde in Escherichia coli: excisable 4NQO-purine adducts.
    Ikenaga M; Ichikawa-Ryo H; Kondo S
    J Mol Biol; 1975 Feb; 92(2):341-56. PubMed ID: 806692
    [No Abstract]   [Full Text] [Related]  

  • 20. Excision repair of DNA base damage in human cells treated with the chemical carcinogen 4-nitroquinoline 1-oxide.
    Ikenaga M; Takebe H; Ishii Y
    Mutat Res; 1977 Jun; 43(3):415-27. PubMed ID: 408672
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.